Find clinical trials for COVID-19 in New York, NY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
COVID-19 trials near New York, NY, USA:
for infectious pneumonia acquired in the community (CAP), including COVID-19.Secondary objectives:- To determine the effect of repa...
Phase 3
New York, New York, United States and 106 other locations
The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-...
Phase 3
New York, New York, United States and 217 other locations
known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...
Phase 2, Phase 3
Hackensack, New Jersey, United States and 214 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
New York, New York, United States and 59 other locations
The purpose of this study is to understand the safety and effects of a combined influenza and COVID-19 vaccine. This combined vacci-...
Phase 3
New York, New York, United States and 159 other locations
studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...
Phase 2, Phase 3
Brooklyn, New York, United States of America and 114 other locations
the study vaccine (called COMIRNATY) for the potential prevention of COVID-19. This study is seeking participants who:1. Are age \<...
Phase 4
New York, New York, United States and 39 other locations
improve lung function in patients that were hospitalized for severe COVID-19-related illness and continue to experience post-acute ...
Phase 2
New York, New York, United States and 3 other locations
to treat inflammatory lung injury associated with severe or critical COVID-19 infection.On evaluation for enrollment, participant w...
Phase 3
New York, New York, United States
The study will evaluate the safety, tolerability, reactogenicity, and effectiveness of mRNA-1273.214 severe acute respiratory syndrome coronavirus 2...
Phase 2
Stony Brook, New York, United States and 39 other locations
Clinical trials
Research sites
Resources
Legal